Sobo will review your medical history, goals, current medications, weight history, and risk factors to determine whether GLP-1 therapy is appropriate
It was discovered in the saliva of the Gila monster, a venomous lizard found in the American southwest, although no one knows why the lizard produces a molecule that replicates the action of GLP-1 when injected twice a day
Keep a simple log noting which site you used each week
Retatrutide: How the Triple Agonist Compares to Tirzepatide Quick Answer Retatrutide is a synthetic 26-amino acid peptide that simultaneously activates three receptor pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
In matched-duration trial comparisons, retatrutide has shown greater average body weight reduction than tirzepatide, though no completed head-to-head Phase 3 trial exists yet